Drug Targets for Plasmodium falciparum: A Post-Genomic Review/Survey
Tipo de material:
TextoSeries ; Mini-Reviews in Medicinal Chemistry, 6(2), p.177-202, 2006Trabajos contenidos: - Iwei Yeh
- Russ B. Altman
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Documentos solicitados
|
CICY Documento préstamo interbibliotecario | Ref1 | B-10481 (Browse shelf(Opens below)) | Available |
Over 300 million cases of malaria each year cause significant morbidity and mortality. Growing drugresistance among the Plasmodia that cause malaria motivates the development of additional anti-malarial drugs. This review summarizes the current state of knowledge about potential drug targets for malaria. The recently sequenced malaria genome data clarifies parasite metabolic pathways, and more metabolic targets have been identified.
There are no comments on this title.
Log in to your account to post a comment.
